State Street’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9M | Buy |
5,138,310
+1,904,798
| +59% | +$4.4M | ﹤0.01% | 2485 |
|
|
2025
Q1 | $4.49M | Sell |
3,233,512
-3,240,855
| -50% | -$4.5M | ﹤0.01% | 2926 |
|
|
2024
Q4 | $11.2M | Buy |
6,474,367
+3,005,299
| +87% | +$5.2M | ﹤0.01% | 2560 |
|
|
2024
Q3 | $6.97M | Buy |
3,469,068
+150,647
| +5% | +$303K | ﹤0.01% | 2803 |
|
|
2024
Q2 | $7.43M | Buy |
3,318,421
+2,978,901
| +877% | +$6.67M | ﹤0.01% | 2739 |
|
|
2024
Q1 | $974K | Buy |
339,520
+196,300
| +137% | +$563K | ﹤0.01% | 3478 |
|
|
2023
Q4 | $253K | Buy |
143,220
+3,200
| +2% | +$5.66K | ﹤0.01% | 3840 |
|
|
2023
Q3 | $442K | Buy |
140,020
+25,100
| +22% | +$79.3K | ﹤0.01% | 3696 |
|
|
2023
Q2 | $76K | Hold |
114,920
| – | – | ﹤0.01% | 4296 |
|
|
2023
Q1 | $91.7K | Hold |
114,920
| – | – | ﹤0.01% | 4344 |
|
|
2022
Q4 | $260K | Buy |
114,920
+37,500
| +48% | +$84.8K | ﹤0.01% | 4009 |
|
|
2022
Q3 | $149K | Hold |
77,420
| – | – | ﹤0.01% | 4266 |
|
|
2022
Q2 | $288K | Sell |
77,420
-421,794
| -84% | -$1.57M | ﹤0.01% | 4049 |
|
|
2022
Q1 | $3.26M | Buy |
499,214
+35,045
| +8% | +$229K | ﹤0.01% | 3377 |
|
|
2021
Q4 | $5.41M | Buy |
464,169
+111,983
| +32% | +$1.3M | ﹤0.01% | 3203 |
|
|
2021
Q3 | $6.56M | Buy |
352,186
+33,567
| +11% | +$625K | ﹤0.01% | 3093 |
|
|
2021
Q2 | $6.76M | Buy |
318,619
+196,478
| +161% | +$4.17M | ﹤0.01% | 3106 |
|
|
2021
Q1 | $2.48M | Buy |
122,141
+12,035
| +11% | +$244K | ﹤0.01% | 3348 |
|
|
2020
Q4 | $2.92M | Buy |
+110,106
| New | +$2.92M | ﹤0.01% | 3204 |
|